Your browser doesn't support javascript.
loading
Clinical outcome of kidney transplantation after bariatric surgery: A single-center, retrospective cohort study.
Outmani, Loubna; Kimenai, Hendrikus J A N; Roodnat, Joke I; Leeman, Marjolijn; Biter, Ulas L; Klaassen, René A; IJzermans, Jan N M; Minnee, Robert C.
Afiliação
  • Outmani L; Division of HPB and Transplant Surgery, Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Kimenai HJAN; Division of HPB and Transplant Surgery, Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Roodnat JI; Division of Nephrology, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Leeman M; Department of Surgery, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands.
  • Biter UL; Department of Surgery, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands.
  • Klaassen RA; Department of Surgery, Maasstad Hospital, Rotterdam, The Netherlands.
  • IJzermans JNM; Division of HPB and Transplant Surgery, Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Minnee RC; Division of HPB and Transplant Surgery, Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.
Clin Transplant ; 35(3): e14208, 2021 03.
Article em En | MEDLINE | ID: mdl-33368652
ABSTRACT
Patients with class II and III obesity and end-stage renal disease are often ineligible for kidney transplantation (KTx) due to increased postoperative complications and technically challenging surgery. Bariatric surgery (BS) can be an effective solution for KTx candidates who are considered inoperable. The aim of this study is to evaluate outcomes of KTx after BS and to compare the outcomes to obese recipients (BMI ≥ 35 kg/m2 ) without BS. This retrospective, single-center study included patients who received KTx after BS between January 1994 and December 2018. The primary outcome was postoperative complications. The secondary outcomes were graft and patient survival. In total, 156 patients were included, of whom 23 underwent BS prior to KTx. There were no significant differences in postoperative complications. After a median follow-up of 5.1 years, death-censored graft survival, uncensored graft survival, and patient survival were similar to controls (log rank test p = .845, .659, and .704, respectively). Dialysis pre-transplantation (Hazard Ratio (HR) 2.55; 95%CI 1.03-6.34, p = .043) and diabetes (HR 2.41; 95%CI 1.11-5.22, p = .027) were independent risk factors for all-cause mortality. A kidney from a deceased donor was an independent risk factor for death-censored graft loss (HR 1.98; 95%CI 1.04-3.79, p = .038). Patients who received a KTx after BS have similar outcomes as obese transplant recipients.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Rim / Cirurgia Bariátrica Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Rim / Cirurgia Bariátrica Idioma: En Ano de publicação: 2021 Tipo de documento: Article